View:
Download DOC
Download PDF
Download XLS
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Palmer Craig E.
(Last) (First) (Middle)
9201 W BROADWAY AVE #650
(Street)
MINNEAPOLIS MN 55445
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/21/2022 		3. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, U.S. Sales
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (1) 02/15/2028 Common Stock 75 0.237 D
Stock Option (1) 02/15/2028 Common Stock 4,425 0.237 D
Stock Option (2) 02/15/2028 Common Stock 4,425 0.237 D
Stock Option (3) 11/11/2023 Common Stock 295 0.237 D
Stock Option (3) 09/10/2024 Common Stock 379 0.237 D
Stock Option (3) 06/30/2025 Common Stock 404 0.237 D
Stock Option (3) 08/06/2025 Common Stock 151 0.237 D
Stock Option (3) 07/12/2026 Common Stock 1,264 0.237 D
Stock Option (3) 09/27/2026 Common Stock 1,896 0.237 D
Stock Option (3) 12/07/2026 Common Stock 75 0.237 D
Stock Option (3) 07/12/2027 Common Stock 151 0.237 D
Stock Option (3) 10/31/2027 Common Stock 151 0.237 D
Stock Option (3) 12/14/2027 Common Stock 75 0.237 D
Stock Option (4) 07/02/2028 Common Stock 1,593 0.395 D
Stock Option (5) 07/12/2028 Common Stock 303 0.395 D
Stock Option (6) 10/07/2028 Common Stock 303 1.186 D
Stock Option (7) 07/23/2029 Common Stock 5,335 3.955 D
Stock Option (7) 07/23/2029 Common Stock 11,732 3.955 D
Stock Option (3) 09/30/2030 Common Stock 7,636 4.35 D
Stock Option (8) 09/30/2030 Common Stock 6,844 4.35 D
Stock Option (9) 09/30/2030 Common Stock 981 4.35 D
Stock Option (9) 09/30/2030 Common Stock 5,800 4.35 D
Stock Option (10) 02/03/2031 Common Stock 10,114 7.119 D
Stock Option (10) 02/03/2031 Common Stock 11,241 7.119 D
Stock Option (10) 02/03/2031 Common Stock 3,930 7.119 D
Stock Option (11) 06/28/2031 Common Stock 12,644 18 D
Stock Option (11) 06/28/2031 Common Stock 16,456 18 D
Stock Option (12) 01/17/2032 Common Stock 38,200 9.08 D
Stock Option (13) 09/30/2030 Common Stock 7,527 4.35 D
Explanation of Responses:
1. Vested as to 25% of the shares on February 16, 2019 and vests as to 1/48th of the shares each month thereafter.
2. Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares each month thereafter.
3. Fully exercisable.
4. Vested as to 25% of the shares on July 3, 2019 and as to 1/48th of the shares each month thereafter.
5. Vested as to 25% of the shares on July 13, 2019 and as to 1/48th of the shares each month thereafter.
6. Vested as to 25% of the shares on October 8, 2019 and as to 1/48th of the shares each month thereafter.
7. Vested as to 25% of the shares on July 24, 2020 and as to 1/48th of the shares each month thereafter.
8. Vested as to 25% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter.
9. Vested as to 25% of the shares on October 1, 2021 and as to 1/48th of the shares each month thereafter.
10. Vests as to 25% of the shares on February 4, 2022 and as to 1/48th of the shares each month thereafter.
11. Vests as to 25% of the shares on June 29, 2022 and as to 1/48th of the shares each month thereafter.
12. Vests as to 25% of the shares on January 18, 2023 and as to 1/48th of the shares each month thereafter.
13. Vested as to 75% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter.
/s/ Amy C. Seidel, Attorney-in-Fact 01/28/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY
       I, Craig E. Palmer, hereby authorize and designate each of
 John Brintnall, Jared Oasheim, Amy C. Seidel and Amra Hoso,
 signing singly, as my true and lawful attorney-in-fact to:
            (1)	prepare and execute for and on my behalf, in my capacity as
 an officer and/or director of CVRx, Inc. (the "Company"), a Form ID and Forms
 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of
 1934 (the "Exchange Act") and the rules and regulations promulgated thereunder
 and other forms or reports on my behalf as may be required to be filed in
 connection with my ownership, acquisition, or disposition of securities of the
 Company, including Form 144;
            (2)	do and perform any and all acts for and on my behalf that may
 be necessary or desirable to complete and execute any such Form ID, Form 3, 4
 or 5 or Form 144, and any amendments to any of the foregoing, and timely file
 any such form with the Securities and Exchange Commission and any stock
 exchange or similar authority; and
            (3)	take any other action of any type whatsoever in connection
 with the foregoing which, in the opinion of such attorney-in-fact, may be to
 my benefit, in my best interest, or legally required of me, it being
 understood that the statements executed by such attorney-in-fact on my behalf
 pursuant to this Power of Attorney shall be in such form and shall contain
 such terms and conditions as such attorney-in-fact may approve in such
 attorney-in-fact's discretion.
       I hereby further grant to each such attorney-in-fact full power and
 authority to do and perform any and every act and thing whatsoever requisite,
 necessary, or proper to be done in the exercise of any of the rights and
 powers herein granted, as fully to all intents and purposes as I might or
 could do if personally present, with full power of substitution or revocation,
 hereby ratifying and confirming all that such attorney-in-fact, or such
 attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
 done by virtue of this Power of Attorney and the rights and powers herein
 granted.  I hereby acknowledge that the foregoing attorneys-in-fact, in
 serving in such capacity at my request, are not assuming, nor is the Company
 assuming, any of my responsibilities to comply with Section 16 of the Exchange
 Act or Rule 144 under the Securities Act of 1933, as amended (the "Securities
 Act").
       This Power of Attorney shall remain in full force and effect until I am
 no longer required to file Form ID or Forms 3, 4 and 5 or Form 144 with
 respect to my holdings of and transactions in securities issued by the
 Company, unless earlier revoked by me in a signed writing delivered to the
 foregoing attorneys-in-fact.  Notwithstanding the foregoing, if any such
 attorney-in-fact hereafter ceases to be at least one of the following: (i) an
 employee of the Company, (ii) a partner of Faegre Drinker Biddle & Reath LLP
 or (iii) an employee of Faegre Baker Drinker Biddle & Reath LLP, then this
 Power of Attorney shall be automatically revoked solely as to such individual,
 immediately upon such cessation, without any further action on my part.
       I hereby revoke all previous Powers of Attorney that have been granted by
 me in connection with my reporting obligations, if any, under Section 16 of
 the Exchange Act and Rule 144 under the Securities Act with respect to my
 holdings of and transactions in securities issued by the Company.
       IN WITNESS WHEREOF, I have caused this Power of Attorney to be duly
 executed as of this 21st day of January, 2022.

/s/ Craig E. Palmer